David M. Knott’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

David M. Knott’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-66,760	Closed	-$415K	–	86
2015 Q1	$415K	Buy	+66,760	New	+$413K	0.09%	55
2014 Q4	–	Sell	-66,760	Closed	-$393K	–	86
2014 Q3	$393K	Sell	66,760 -93,140	-58%	-$568K	0.07%	51
2014 Q2	$1.1M	Hold	159,900	–	–	0.2%	40
2014 Q1	$1.15M	Hold	159,900	–	–	0.22%	40
2013 Q4	$1.06M	Buy	+159,900	New	+$1.09M	0.22%	41

Other funds holding JNP

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

CCM

Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BAMS

Bellevue Asset Management (Switzerland) Kuesnacht, Switzerland $656M AUM 11.45% 1-Year Est. Return

David M. Knott's JNP Position: Q2 2015 in Review

David M. Knott sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q2 2015, closing a stake of 66,760 shares — an estimated $415K sold.

David M. Knott first reported a position in JNP in Q4 2013 and held it in 5 quarters. The position peaked at $1.15M in Q1 2014. 44 funds tracked by Wall St. Rank hold JNP as of Q2 2015.

David M. Knott reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
David M. Knott sold 66,760 Juniper Pharmaceuticals, Inc. Common Stock shares in Q2 2015, an estimated $415K.
David M. Knott first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q4 2013 and held it in 5 quarters.
David M. Knott's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $1.15M in Q1 2014.
44 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q2 2015.

Based on David M. Knott's 13F filing for Q2 2015, filed 12 Aug 2015.